glp 1 and immune system Beyond metabolic benefits: The underexplored immunomodulatory effects of -1/glucagon agonists GLP-1 and the kidney: from

Combined therapy that involves the inhibition of Gln metabolism alongside PD-L1 blockade has been shown to enhance the anti-tumor immune response of T cells (97, 98)

Adverse events linked to GLP-1 medicines The most common side effects of GLP-1RAs are gastrointestinal, including nausea, diarrhea, constipation, and vomiting

Protein intake is key for maintaining muscle mass, and its hard to get enough when using GLP-1s

Defining optimal cost-effective approaches to care, particularly in the management of patients including those with multi-morbidity is essential. They add: New questions arise from the recent cardiovascular outcomes studies